Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety

BACKGROUND: Chronic migraine is associated with significant headache-related disability and psychiatric comorbidity. OnabotulinumtoxinA (BOTOX(®)) is effective and well tolerated in the prophylactic treatment of chronic migraine. This study aimed to provide preliminary data on the efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudreau, Guy P, Grosberg, Brian M, McAllister, Peter J, Lipton, Richard B, Buse, Dawn C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340374/
https://www.ncbi.nlm.nih.gov/pubmed/25733924
http://dx.doi.org/10.2147/IJGM.S70456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340374/
https://www.ncbi.nlm.nih.gov/pubmed/25733924
http://dx.doi.org/10.2147/IJGM.S70456

Ejemplares similares